These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21403042)

  • 21. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
    Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial.
    Young LA; Buse JB; Weaver MA; Vu MB; Mitchell CM; Blakeney T; Grimm K; Rees J; Niblock F; Donahue KE;
    JAMA Intern Med; 2017 Jul; 177(7):920-929. PubMed ID: 28600913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
    Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
    BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.
    Buse JB; Rubin CJ; Frederich R; Viraswami-Appanna K; Lin KC; Montoro R; Shockey G; Davidson JA
    Clin Ther; 2005 Aug; 27(8):1181-95. PubMed ID: 16199244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a self-management education programme on patients with type 2 diabetes in primary care: A randomised controlled trial.
    Gamboa Moreno E; Mateo-Abad M; Ochoa de Retana García L; Vrotsou K; Del Campo Pena E; Sánchez Perez Á; Martínez Carazo C; Arbonies Ortiz JC; Rúa Portu MÁ; Piñera Elorriaga K; Zenarutzabeitia Pikatza A; Urquiza Bengoa MN; Méndez Sanpedro T; Oses Portu A; Aguirre Sorondo MB; Rotaeche Del Campo R;
    Prim Care Diabetes; 2019 Apr; 13(2):122-133. PubMed ID: 30409669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-active call center treatment support (PACCTS) to improve glucose control in type 2 diabetes: a randomized controlled trial.
    Young RJ; Taylor J; Friede T; Hollis S; Mason JM; Lee P; Burns E; Long AF; Gambling T; New JP; Gibson JM
    Diabetes Care; 2005 Feb; 28(2):278-82. PubMed ID: 15677779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.
    Moretto TJ; Milton DR; Ridge TD; Macconell LA; Okerson T; Wolka AM; Brodows RG
    Clin Ther; 2008 Aug; 30(8):1448-60. PubMed ID: 18803987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus.
    Rochester CD; Leon N; Dombrowski R; Haines ST
    Am J Health Syst Pharm; 2010 Jan; 67(1):42-8. PubMed ID: 20044368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
    Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes.
    Phung OJ; Scholle JM; Talwar M; Coleman CI
    JAMA; 2010 Apr; 303(14):1410-8. PubMed ID: 20388897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis.
    Umpierre D; Ribeiro PA; Kramer CK; Leitão CB; Zucatti AT; Azevedo MJ; Gross JL; Ribeiro JP; Schaan BD
    JAMA; 2011 May; 305(17):1790-9. PubMed ID: 21540423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of one-year of specialist care of patients with type 2 diabetes: a multi-center prospective survey (JDDM 2).
    Sone H; Kawai K; Takagi H; Yamada N; Kobayashi M
    Intern Med; 2006; 45(9):589-97. PubMed ID: 16755089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators.
    Levin SR; Coburn JW; Abraira C; Henderson WG; Colwell JA; Emanuele NV; Nuttall FQ; Sawin CT; Comstock JP; Silbert CK
    Diabetes Care; 2000 Oct; 23(10):1478-85. PubMed ID: 11023140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of motivational interviewing on glycaemic control and perceived competence of diabetes self-management in patients with type 1 and type 2 diabetes mellitus after attending a group education programme: a randomised controlled trial.
    Rosenbek Minet LK; Wagner L; Lønvig EM; Hjelmborg J; Henriksen JE
    Diabetologia; 2011 Jul; 54(7):1620-9. PubMed ID: 21455729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial comparing intensive and passive education in patients with diabetes mellitus.
    Raji A; Gomes H; Beard JO; MacDonald P; Conlin PR
    Arch Intern Med; 2002 Jun; 162(11):1301-4. PubMed ID: 12038949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
    Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
    Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness of patient education methods for type 2 diabetes: a randomized controlled trial.
    Sperl-Hillen J; Beaton S; Fernandes O; Von Worley A; Vazquez-Benitez G; Parker E; Hanson A; Lavin-Tompkins J; Glasrud P; Davis H; Adams K; Parsons W; Spain CV
    Arch Intern Med; 2011 Dec; 171(22):2001-10. PubMed ID: 21986350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention.
    Odegard PS; Goo A; Hummel J; Williams KL; Gray SL
    Ann Pharmacother; 2005 Mar; 39(3):433-40. PubMed ID: 15701763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.